Ragazzi ottime news da Histogen (unico prodotto al quale io ho sempre creduto):
http://www.histogen.com/aboutus/news_events.htm#38
Vi incollo qualche pezzo giusto per farvi capire:
significant increase in vellus hair count (p=0.033) was seen for the first time, supporting the hypothesis that the HSC treatment
rescues dying follicles, in addition to
converting vellus to terminal hairs and increasing the number of hairs per follicle. Statistical significance continued to be seen at the 24 week time point.
Particularly compelling is the growth seen in more difficult types and stages of hair loss.
Without limitations to treatment area, age or stage of balding, HSC has the potential to expand the hair restoration market by offering a successful option to those that currently have none.
In both the pilot and Phase I/II clinical trial, HSC treatment has shown efficacy across age groups,
with subjects age 40-59 seeing cosmetically significant results beginning at 12 weeks, including a mean increase of 39% in terminal hairs and 19.4% in total hair count in this age group in the current trial.
Subjects receiving HSC in the
temporal recession , which is known to be more difficult to treat than other areas of hair loss, saw marked improvement in terminal hair
count, with a mean increase of 22.6% at 12 weeks and 25.2% at the 24 week time point.
Se tutto ciò è vero bhe, che dire, siamo a cavallo!
PS: Ho dimenticato di dire che si è dimostrato un prodotto altamente sicuro!
http://www.histogen.com/aboutus/news_events.htm#38
Vi incollo qualche pezzo giusto per farvi capire:
significant increase in vellus hair count (p=0.033) was seen for the first time, supporting the hypothesis that the HSC treatment
rescues dying follicles, in addition to
converting vellus to terminal hairs and increasing the number of hairs per follicle. Statistical significance continued to be seen at the 24 week time point.
Particularly compelling is the growth seen in more difficult types and stages of hair loss.
Without limitations to treatment area, age or stage of balding, HSC has the potential to expand the hair restoration market by offering a successful option to those that currently have none.
In both the pilot and Phase I/II clinical trial, HSC treatment has shown efficacy across age groups,
with subjects age 40-59 seeing cosmetically significant results beginning at 12 weeks, including a mean increase of 39% in terminal hairs and 19.4% in total hair count in this age group in the current trial.
Subjects receiving HSC in the
temporal recession , which is known to be more difficult to treat than other areas of hair loss, saw marked improvement in terminal hair
count, with a mean increase of 22.6% at 12 weeks and 25.2% at the 24 week time point.
Se tutto ciò è vero bhe, che dire, siamo a cavallo!
PS: Ho dimenticato di dire che si è dimostrato un prodotto altamente sicuro!
!][